Bevacizumab addition to chemotherapy showed significant progression-free survival benefits in high-risk epithelial ovarian cancer patients but not in overall survival. The BEV1L study used real ...

A new study of a cancer treatment called HIPEC, heated intraperitoneal chemotherapy, is showing good results when it comes to treating women with metastatic epithelial ovarian cancer. Tampa ...

On World Ovarian Cancer Day, doctors share key symptoms ... in life are potentially curable with normal life expectancy. Epithelial ovarian tumours need to be staged surgically to know about ...

Genome-wide association studies (GWAS) have identified 18 loci associated with serous ovarian cancer (SOC ... PAX8 expression in ovarian surface epithelial cells. Hum Pathol 46: 948–956.

was previously evaluated as a first-line treatment for patients with BRCA non-mutated advanced epithelial ovarian cancer. Despite proving improvements in progression-free survival, the Keytruda-Ly ...

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

Ovarian cancer is a condition of the growth of cells that forms in the ovaries. The cells multiply rapidly and potentially invade and destroy healthy body tissue. The female reproductive system ...

"These results provide contemporary evidence on real-world bevacizumab use with 1L [first-line] chemotherapy in patients with advanced EOC [epithelial ovarian cancer]," they added. "Following the ...

A review now published in the Journal of Experimental & Clinical Cancer Research offers ... Most (more than 90%) ovarian cancers are classified as "epithelial" and are believed to arise from ...

Eligible study participants were adult females for whom there was a high clinical suspicion or diagnosis of epithelial ovarian cancer. Planned surgeries included primary surgical cytoreduction, ...

A Phase II study of vintafolide plus pegylated liposomal doxorubicin (PLD) versus PLD alone in patients with platinum-resistant ovarian cancer showed a statistically significant improvement in ...

Get Instant Summarized Text (Gist) A new symptom assessment tool is being developed to facilitate earlier diagnosis of ovarian cancer, which currently has a five-year survival rate of 49% due to ...